Vanda Pharmaceuticals (FRA:VM4) Days Sales Outstanding : 68.02 (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Vanda Pharmaceuticals Days Sales Outstanding?

Vanda Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was €32.5 Mil. Vanda Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was €43.7 Mil. Hence, Vanda Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 68.02.

The historical rank and industry rank for Vanda Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:VM4' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.69 Med: 43.14 Max: 65.05
Current: 65.05

During the past 13 years, Vanda Pharmaceuticals's highest Days Sales Outstanding was 65.05. The lowest was 20.69. And the median was 43.14.

FRA:VM4's Days Sales Outstanding is ranked better than
55.77% of 893 companies
in the Biotechnology industry
Industry Median: 73.01 vs FRA:VM4: 65.05

Vanda Pharmaceuticals's Days Sales Outstanding increased from Mar. 2023 (42.62) to Mar. 2024 (68.02).

Vanda Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Vanda Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanda Pharmaceuticals Days Sales Outstanding Chart

Vanda Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

43.76

43.32

41.00

45.88

65.04

Vanda Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															42.62	57.88	73.34	64.57	68.02

Competitive Comparison of Vanda Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Vanda Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vanda Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vanda Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Vanda Pharmaceuticals's Days Sales Outstanding falls into.

Vanda Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Vanda Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (31.635	+	31.32)	/	2 )	/	176.651	*	365
=	31.4775					/	176.651	*	365
=	65.04

Vanda Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (31.32	+	33.776)	/	2 )	/	43.665	*	365 / 4
=	32.548					/	43.665	*	365 / 4
=	68.02

Vanda Pharmaceuticals (FRA:VM4) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Vanda Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Vanda Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Vanda Pharmaceuticals (FRA:VM4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vanda Pharmaceuticals Inc (FRA:VM4) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

VNDA:USA VM4:Germany

Address

2200 Pennsylvania Avenue NW, Suite 300 E, Washington, DC, USA, 20037

Website

https://www.vandapharma.com

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include VHX-896 and ASO Molecules. The majority of revenue is derived from HETLIOZ product sales.

Vanda Pharmaceuticals (FRA:VM4) Headlines

No Headlines